Adenosine A2A Agonist Improves Lung Function During Ex Vivo Lung Perfusion

Annals of Thoracic Surgery - Netherlands
doi 10.1016/j.athoracsur.2011.06.062
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ex Vivo Lung Perfusion

Artificial Organs
MedicineBioengineeringBiomaterialsBiomedical Engineering
2019English

Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation

Current Transplantation Reports
2015English

Ex Vivo Lung Perfusion Rehabilitates Sepsis-Induced Lung Injury

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2017English

Lung Transplantation After Ex-Vivo Lung Perfusion in Two Scandinavian Centres

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

A Porcine Ex Vivo Lung Perfusion Model to Investigate Bacterial Pathogenesis

mBio
VirologyMicrobiology
2019English

Ex-Vivo Lung Perfusion Versus Standard Protocol Lung Transplantation—mid-Term Survival and Meta-Analysis

Annals of Cardiothoracic Surgery
SurgeryCardiovascular MedicineCardiology
2020English

Editorial: Regadenoson: An Adenosine A2A Receptor Agonist for Pharmacological Myocardial Perfusion Imaging

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2014English

An Observational Study of Donor Ex Vivo Lung Perfusion in UK Lung Transplantation: DEVELOP-UK

Health Technology Assessment
MedicineHealth Policy
2016English

Pretreatment Strategy With Adenosine A2A Receptor Agonist Attenuates Reperfusion Injury in a Preclinical Porcine Lung Transplantation Model

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy